A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney Disease

NCT07647133 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

249

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease

Interventions

DRUG: SAL0140 Tablets
DRUG: SAL0140 Tablets
DRUG: SAL0140 placebo

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.